Applications of Liquid Biopsy Webinar Series - Colorectal Cancer

Learning objectives: 

• Understand the concept and potential clinical applications of ctDNA in early-stage colorectal cancer in terms of detection of minimal residual disease and molecular relapse monitoring
• Understand the concept and potential clinical applications of ctDNA for advanced cancer genotyping and evaluation of tumour response
• Understand the concept and potential clinical applications of ctDNA to capture tumour evolution and drug resistance biomarkers

This webinar aims to review and discuss data for liquid biopsy-based assessments as endpoints of antitumour activity in clinical trials, understand the potential and limitations of liquid biopsy-based tumour genomic profiling for patient stratification and detection of predictive biomarkers of response to therapy, and to discuss how tumour heterogeneity and evolution assessed via liquid biopsy assays may improve colorectal cancer treatment strategies.